COG-101

N/A

Report date: 2025/08/14 17:46:55

Base Information

Drug NameCOG-101

Drug Alias NameCOG-101

ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vectorCell and gene therapy > Gene therapy > Gene editing > CRISPRCell and gene therapy > Gene therapy > LNP

Mechanisms of ActionSerotonin 2a (5-HT2a) receptor modulators

TargetsSerotonin 2a (5-HT2a) receptor

Therapy Area/IndicationsCognitive DysfunctionAnxiety

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesCognigenics Inc

China Registration ClassN/A

Develop Information

Active CompaniesCognigenics Inc

Inactive CompaniesN/A

Active IndicationsCognitive DysfunctionAnxiety

Inactive IndicationsN/A

Other Information

ATC CodeN/A